Replies to post #221165 on Biotech Values

[DewDiligence]

AKRX may file for bankruptcy due to opioid-related liabilities:

https://www.prnewswire.com/news-releases/akorn-announces-new-extension-of-standstill-with-lenders-and-agrees-to-pursue-a-sale-of-its-business-301004100.html

Akorn, Inc…today announced it has reached an agreement with certain of its lenders to extend the standstill period. The agreement defines a path forward and outlines milestones to execute a sale of Akorn's business, potentially using Chapter 11 protection in order to address Akorn's litigation-related overhangs and execute a transaction that maximizes value.

Doug Boothe, Akorn's President and Chief Executive Officer, commented, “Akorn is a fundamentally strong business with exciting opportunities ahead.”

May you live in exciting times!